CAS 179552-74-0: N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitro-4-Quinazolinamine

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine is a synthetic, nonsteroidal antiinflammatory agent. It is used in the treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The chemical structure of this drug consists of a butene chain with a potassium hydroxide substituent and an amide group. This drug has been shown to have antiinflammatory properties and may be used to treat inflammatory diseases such as osteoarthritis. This drug is excreted through the kidneys and should be used cautiously in patients with kidney disease. Excipients are added to drugs to help with stability, flowability, and dissolution. Although these substances do not affect the efficacy or safety of the active ingredient, they can influence how well the drug works. Maxacalcitol is an example of an excipient that is added

Dacomitinib Intermediate 2

Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer.